课题基金 / 基金详情

Expansion of hematopoietic stem cells by Angiopoietin-like 2

Expansion of hematopoietic stem cells by Angiopoietin-like 2
通过血管生成素样 2 扩增造血干细胞
批准号:
7340625
负责人:
CHENGCHENG ZHANG
金额:
$5.6万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-07-01 至 2011-06-30

项目摘要

项目成果

CHENGCHENG ZHANG的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Hematopoietic stem cells (HSCs) are a rare population of cells that can self-renew and differentiate into all blood cell types. They form the basis of bone marrow transplantation for treatment of leukemia and other cancers. However, the clinical applications of HSCs are severely hampered by our limited understanding of the extracellular and intracellular signals that govern HSC cell fates and by the difficulty in ex vivo expansion of these cells. Recently I identified day 15 mouse fetal liver CD3+Ter119- cells as a novel cell population that supports HSC expansion. From these cells I identified insulin-like growth factor 2 (IGF-2) and Angiopoietin-like protein 2 (Angptl2) as the factors that stimulate the ex vivo expansion of HSCs. In combination with other growth factors, Angptl2 stimulates a greater than 20-fold expansion of HSCs in 10 days of culture. Angptl2 is largely unstudied and its receptor(s) and signal transduction are unknown. I hypothesize that Angptl2 interacts with a currently unknown receptor on the surface of HSCs, and this results in activation of specific intracellular signaling pathway(s) and induction of transcription of targets gene(s) that are required for self-renewal or survival of HSCs. To this end, will test the hypotheses that Angptl2, IGF-2, and other growth factors stimulate HSC expansion by inducing their self-renewal and/or survival, and dissect the specific intracellular signal transduction pathway(s) and transcriptional activation induced by Angptl2, in both cell lines and in HSCs. Moreover, I will use expression cloning to isolate the Angptl2 cell surface receptor(s). This work will provide new insights into a novel link between Angptl2, its membrane receptor(s), and the regulation of HSC expansion. Through this proposed research, the applicant will receive training in advanced molecular biology, stem cell biology, protein biochemistry, and system biology in order to gain the requisite skills and knowledge to become an independent investigator.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Reprogramming myeloid cells to inhibit cancer development
  • 批准号:
    10687107
  • 项目类别:
  • 资助金额:
    $36.62万
  • 财政年份:
    2022
  • 负责人:
    CHENGCHENG ZHANG
  • 依托单位:
ITIM-receptors for cancer treatment
  • 批准号:
    10360629
  • 项目类别:
  • 资助金额:
    $56.56万
  • 财政年份:
    2020
  • 负责人:
    CHENGCHENG ZHANG
  • 依托单位:
ITIM-receptors for cancer treatment
  • 批准号:
    10561601
  • 项目类别:
  • 资助金额:
    $56.94万
  • 财政年份:
    2020
  • 负责人:
    CHENGCHENG ZHANG
  • 依托单位:
The role of inhibitory receptors in leukemia development
  • 批准号:
    9001318
  • 项目类别:
  • 资助金额:
    $32.99万
  • 财政年份:
    2013
  • 负责人:
    CHENGCHENG ZHANG
  • 依托单位:
国内基金
海外基金
骨髓抑制再生单个核细胞移植通过调节线粒体功能在脑缺血再灌注损伤中的神经保护机制研究
  • 批准号:
    82371301
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    李轶
  • 依托单位:
对12个造血候选基因在小鼠骨髓抑制和再生过程中作用的筛查
  • 批准号:
    30570787
  • 项目类别:
    面上项目
  • 资助金额:
    8.0万元
  • 批准年份:
    2005
  • 负责人:
    毛文伟
  • 依托单位: